Alteration of N-glycans and Expression of Their Related Glycogenes in the Epithelial-Mesenchymal Transition of HCV29 Bladder Epithelial Cells

作者：Guo, Jia; Li, Xiang; Tan, Zengqi; Lu, Wei; Yang, Ganglong; Guan, Feng^*

来源：Molecules, 2014, 19(12): 20073-20090.

DOI：10.3390/molecules191220073

• epithelial-mesenchymal transition
• glycogene
• mass spectrometry
• microarray
• N-glycan

The epithelial-mesenchymal transition (EMT) is an essential step in the proliferation and metastasis of solid tumor cells, and glycosylation plays a crucial role in the EMT process. Certain aberrant glycans have been reported as biomarkers during bladder cancer progression, but global variation of N-glycans in this type of cancer has not been previously studied. We examined the profiles of N-glycan and glycogene expression in transforming growth factor-beta (TGF beta)-induced EMT using non-malignant bladder transitional epithelium HCV29 cells. These expression profiles were analyzed by mass spectrometry, lectin microarray analysis, and GlycoV4 oligonucleotide microarray analysis, and confirmed by lectin histochemistry and real-time RT-PCR. The expression of 5 N-glycan-related genes were notably altered in TGF beta-induced EMT. In particular, reduced expression of glycogene man2a1, which encodes alpha-mannosidase 2, contributed to the decreased proportions of bi-, tri- and tetra-antennary complex N-glycans, and increased expression of hybrid-type N-glycans. Decreased expression of fuca1 gene, which encodes Type 1 alpha-L-fucosidase, contributed to increased expression of fucosylated N-glycans in TGF beta-induced EMT. Taken together, these findings clearly demonstrate the involvement of aberrant N-glycan synthesis in EMT in these cells. Integrated glycomic techniques as described here will facilitate discovery of glycan markers and development of novel diagnostic and therapeutic approaches to bladder cancer.

• 出版日期2014-12
• 单位江南大学